Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. The company is leveraging the Rhythm Engine -- comprised of its TEMPO Registry, GO-ID genotyping study and Uncovering Rare Obesity program -- to improve the understanding, diagnosis and potentially the treatment of these disorders. For healthcare professionals, visit www.UNcommonObesity.com for more information. For patients and caregivers, visit www.LEADforRareObesity.com for more information.

genetics obesity peptides metabolism rare disease biotechnology Pharmaceuticals Research Health Medicine Clinical Trials Endocrinology Orphan disease Science Advocacy Epidemiology Orphan drugs Rare disease metabolic B2B B2C Biotech SaaS Commercial Physical Research Biotechnology